NCT01851850View on ClinicalTrials.gov

Continuation Treatment Protocol for Patient Who Participated in the BIA 9-1067-302 Clinical Trial

PHASE3CompletedINTERVENTIONAL
Enrollment

1

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

May 24, 2016

Study Completion Date

May 24, 2016

Conditions
Parkinson Disease
Interventions
DRUG

Opicapone

25mg or 50mg once per day

Trial Locations (1)

49100

Rabin Medical Center, Petach Tiqva

All Listed Sponsors
lead

Rabin Medical Center

OTHER

NCT01851850 - Continuation Treatment Protocol for Patient Who Participated in the BIA 9-1067-302 Clinical Trial | Biotech Hunter | Biotech Hunter